News Tag: Other Corporate Information

In October will 30 patients in the advanced home healthcare, in Region Stockholm, will receive for the first time a robot that will help them take their medicine. The aim is to reduce the risk of medication mistreatment, underdosing and overdosing or mixing up medication. In some cases, the risk of abuse can also be reduced.

— Pharmaceutical robots mean major positive changes for patient safety. If the patient does not take their medication, an alarm is sent to our nurses, says Maria Frick, registered pharmacist at Aleri's local health care.

Aleris has investigated the possibility of introducing so-called pharmaceutical robots within advanced home healthcare in the Stockholm Region. A total of 30 Dosell pharmaceutical robots from iZafe have been purchased. During October, the pharmaceutical robot will be introduced to the first patient treated in advanced healthcare at home (ASIH).

— We see great opportunities with pharmaceutical robots in specialist healthcare. Innovation and technology that can help our patients to greater independence while increasing or maintaining patient safety is important to us, says Maria Frick.

It is the first time a pharmaceutical robot has been integrated into advanced home healthcare.

— We are extremely proud to continue to contribute to helping several patient groups and making everyday life easier with our unique pharmaceutical robot. We look forward to starting the implementation of Dosell at Aleris. After three months, an evaluation is carried out to see how many pharmaceutical robots the business wishes to bring in, says Anders Segerström, CEO iZafe Group.

For certain patient groups, the robot is an important aid. Last year, the poison information center received a number of calls about patients who, due to wrong dosage or mix-up, had taken the wrong medicine. 61 percent of them were recommended to seek medical care. Many serious overdoses are found in the group.

— A medication robot tells when a patient should take their medication, at the same time medication for future administration occasions is inaccessible, says Maria Frick.

Another advantage of pharmaceutical robots is increased efficiency and the opportunity to spend resources on more value-creating activities.

Not all patients in specialist healthcare are suitable for a medication robot, an assessment is always made and confirmed with the doctor that the patient can manage their medication with and that it is a suitable solution for this particular individual.

This is how a pharmaceutical robot works in specialist healthcare
The medication robot, no bigger than a shoebox, is placed in the patient's home. The robot is loaded with the patient's prescribed medication packaged in sachets. The medication robot reads the time for the next medication intake and at the correct date and time a dose bag is fed forward and thus becomes available to the patient. To remind you that it is time to take medicine, the robot signals with light and sound.

If for some reason the patient does not remove his dose bag from the robot, the patient's nurse will receive an alarm about this and then contact the patient, either through a phone call or a visit.

For further information contact:
Kenan Harbas, press manager Aleris, +46 707 834 203
Anders Segerström, CEO iZafe Group, +46 70-875 14 12

About Aleris
Aleri's vision is to lead the way to tomorrow's health and care. Through innovative solutions, we create opportunities for a better and healthier life while contributing to increased accessibility and social benefit. Aleris is a Scandinavian healthcare provider with two million patient visits a year and provides specialist healthcare at over 130 locations in Sweden, Norway and Denmark.

About Dosell
The pharmaceutical robot Dosell is a Swedish-made digital aid for safer medication at home and for residents in nursing homes. Dosell is integrated into welfare platforms and sold as one of several integrated digital aids via partners. Dosell notifies the patient when it is time to take the medication, and if the medication is not taken despite the reminders, Dosell alerts healthcare staff or relatives who can quickly prevent an injury from occurring as well as improve compliance and thereby minimize medication-related injuries.

"Getting the medicine in sachets is completely new to the Italian market and our concept is based on local pharmacies purchasing a machine to enable their customers to have the medicine delivered in sachets. In a short time, we have now succeeded in installing machines for packing medicine into sachets in 12 pharmacies. These pharmacies have in turn gotten 2,000 of their customers to start getting their medicines delivered in sachets. Of these, about 95% are users in nursing homes. We currently have a rate of 2 new pharmacies a month installing a machine.
 
We will now start actively selling Dosell to these customers, but we will also start tests to introduce corportare version of Dosell, as most of our customers patients are now in nursing homes." says Alessandro Iadecola, CEO Remedio S.R.L.
 
 
"Getting several pharmacies to start packaging the medicines in sachets is absolutely crucial for Dosell, which is based on loading the medicine robot with these sachets. It will be exciting to follow the development on the Italian market, where it is now finally starting to gain momentum. Extra happy that so many nursing homes are starting to show interest in getting the medicine in sachets, as there are 3,000 nursing homes with over 300,000 beds in Italy." says Anders Segerström, CEO of iZafe Group AB.

If all the warrants of series TO10B are exercised, the Company will receive approximately SEK 9.2 million before issuing costs. In order to prevent the warrants expiring without value, the holder must actively subscribe for new shares, no later than October 11, 2022. Alternatively, the holder may sell the warrants, no later than today, October 7, 2022. Please be aware that certain nominees may close their subscriptions earlier than October 11, 2022. Complete terms and conditions for the warrants are available on the Company’s website, www.izafegroup.com.

Summarized terms for the warrants of series TO10B:

Exercise period: September 27, 2022 – October 11, 2022.

Exercise price: SEK 0.26 per share of series B.

Issue size: 35,435,674 warrants of series TO10B, which entitles to subscription of 35,435,674 shares of series B. If all the warrants are exercised, The Company will receive approximately SEK 9.2 million before issuing costs.

Last day for trading warrants of series TO10B: October 7, 2022.

Share capital and dilution: If all warrants are exercised the share capital will increase with SEK 7,087,134.80, from SEK 14,174,861.60 to SEK 21,261,996.40. If all warrants are exercised the number of shares will increase with 35,435,674 shares of series B, in total the number of shares in the Company will increase from 70,874,308 shares to 106,309,982 shares (600,000 shares of series A and 105,709,982 shares of series B). The dilution at full exercise of all warrants amounts to approximately 33.33 percent of the number of shares and 31.72 percent of the votes in the Company.
Note that the warrants of series TO10B that are not exercised at the latest October 11, 2022, or sold at the latest October 7, 2022, will expire without value. For the warrants not to lose their value, the holder must actively subscribe for new shares or sell the warrants.

Advisors
Mangold Fondkommission AB is the financial advisor and Eversheds Sutherland Advokatbyrå AB is the legal advisor to the Company in connection with the exercise of the warrants of series TO10B.

"We see an increased demand from municipalities that wish to implement Dosell, the period for implementation is short before the Christmas holiday starts, which means that we choose to start these two municipalities under our own auspices.
The municipalities will start with a low volume to find the right processes and routines to be able to introduce larger volumes of pharmaceutical robots. When the municipalities are to introduce several pharmaceutical robots, these will be handed over to our partners." Says Anders Segerström, CEO iZafe Group AB.

iZafe has received subscriptions from the Board of Directors, management team and the incoming Chairman of the Board as follows.

Summarized terms for the warrants of series TO10B:

Exercise period: September 27, 2022 – October 11, 2022.

Exercise price: SEK 0.26 per share of series B.

Issue size: 35,435,674 warrants, which entitles to subscription of 35,435,674 shares of series B. If all the warrants are exercised, The Company will receive approximately SEK 9.2 million before issuing costs.

Last day for trading warrants of series TO10B: October 7, 2022.

Advisors
Mangold Fondkommission AB is the financial advisor and Eversheds Sutherland Advokatbyrå AB is the legal advisor to the Company in connection with the exercise of the warrants of series TO10B.

The municipality, which has approximately 3,300 residents aged 65 and over, initially starts with 25 Dosells and then gradually increases the number.

About Hepro
HEPRO AS is a modern and future-oriented competence company that develops, produces and sells aids and welfare technology of high quality and clean design. The company was founded in 1987 and has extensive experience in developing products and solutions that will make everyday life easier for their customers. Their vision is to give their customers the opportunity to manage themselves, participate actively in their own everyday lives and stay longer at home. Hepro is owned by the Stockholm-based listed AddLife Group. AddLife has approx. 70 st. independent subsidiaries and over 1800 employees.

The municipality, which has approx. 5,171 residents aged 65 and over, will initially start with 20 Dosells and then gradually increase the number.

"We look forward to starting the implementation of the medicine robot Dosell. Careium is driven by a genuine concern for our users and their needs always come first. Remembering to take your daily medication can mean the difference between life and death. Despite this, many people often forget to take their medicine and then a medicine robot can be of great use. Dosell contributes to better compliance and that drug-related injuries are minimized," says Arvid Bakken, Country Director Norway.

About Careium
Careium is one of the leading players in welfare technology in Europe and approximately 400,000 people use their services. The vast majority of these are connected to one of their four alarm centers in Sweden, Norway and Great Britain. The alarm centers receive more than 25,000 alarms a day. Doro Care recently changed its name to Careium. Doro acquired Caretech in 2014, which became the starting point for what is today Careium. Read more at careium.com